InSitu Biologics is an emerging biotech company focusing on development of INSB200, an opioid-free long-lasting product for post-op pain control. Using disruptive technology to address an unmet need, InSitu’s mission is to avoid exposing surgical patients to opioids. INSB200 is a single-injection nerve block containing the anesthetic ropivacaine that has pain-killing efficacy to 72+ hours.
